Correlation of Platelet Function,Coagulation and Fibrinolytic System Function in Elderly Patients with Type 2 Diabetes
-
摘要:
目的 探讨老年2型糖尿病患者的血小板功能、凝血功能、纤溶系统的特点。 方法 选取193例患者,按WHO标准诊断标准分为2型糖尿病组(DM组,97例)和对照组(NC组,96例)。收集所有患者的性别、年龄、糖尿病病程、吸烟史、SBP、DBP、BMI、FPG、2 hPG、HbA1c、FC、TC、TG 、ACT、PF、D-2聚体等指标,比较以上指标的组间差异。并对PF、D-2聚体相关因素行Pearson 相关性分析及多元线性回归分析。 结果 (1)糖尿病组 BMI、D-2聚体、ACT较对照组高,组间差异有统计学意义(P < 0.05);(2)Pearson 相关性分析:D-2聚体值与年龄、BMI、糖尿病病程具有显著正相关性(P < 0.05),与糖化血红蛋白百分比正相关性更为显著(P < 0.01);PF与餐后2 h胰岛素、餐后2 h C肽具有显著负相关性(P < 0.05),与空腹血糖正相关性更为显著(P < 0.01);(3)多重线性回归分析:年龄和糖化血红蛋白百分比与D-2聚体存在正相关关系(P < 0.05);空腹血糖与PF存在正相关关系,餐后2 h胰岛素与PF存在负相关关系(P < 0.05)。 结论 老年2型糖尿患者存在血小板功能、凝血功能、纤容系统功能异常,高血糖、胰岛功能差可能是其主要原因。 Abstract:Objective To investigate the platelet function, coagulation function and fibrinolytic system in elderly patients with type 2 diabetes. Methods 193 patients were divided into type 2 diabetes group (group DM, 97 cases) and control group (group NC, 96 cases) according to WHO standard diagnostic criteria.The gender, age, duration of diabetes, smoking history, SBP, DBP, BMI, FPG, 2 h PG, HbA1c, FC, TC, TG, ACT, PF, and aggregation polymer were collected and compared among the patients. Pearson correlation analysis and multiple linear regression analysis were performed on the related factors of PF and D-2 polymer. Results (1) The levels of BMI, D-2 polymer and ACT in the DM group were higher than those in the control group (P < 0.05). (2) Pearson correlation analysis: The value of D-2 aggregate was positively correlated with age, BMI, and duration of diabetes (P < 0.05), and positively correlated with the percentage of glycosylated hemoglobin (P < 0.01). PF had significant negative correlation with the levels of 2 h postprandial insulin and C peptide (P < 0.05), and more significant positive correlation with fasting blood glucose (P < 0.01). (3) Multiple linear regression analysis: age and percentage of glycosylated hemoglobin were positively correlated with D-2 polymer (P < 0.05). There was a positive correlation between fasting blood glucose and PF, and a negative correlation between insulin and PF at 2 hours after meal (P < 0.05). Conclusion There are abnormal platelet function, coagulation function and fibrous function system in elderly patients with type 2 diabetes mellitus, high state of blood glucose and poor function of isolated islets may be the main reasons. -
表 1 糖尿病组与非糖尿病组的一般临床资料比较(
$ \bar x \pm s $ )Table 1. Comparison of general clinical data between diabetic group (group DM) and non-diabetic group (group NC) (
$ \bar x \pm s $ )指标 糖尿病组( 98 例) 对照组( 96 例) t/χ2 P 年龄(岁) 68.76 ± 6.09 69.40 ± 6.06 −0.671 0.502 BMI(kg/m2) 24.43 ± 2.82 23.28 ± 2.81 2.791 0.006* 收缩压(mm Hg) 137.40 ± 20.29 135.30 ± 21.87 0.702 0.484 舒张压(mm Hg) 81.09 ± 11.19 81.30 ± 11.17 −0.130 0.897 糖化血红蛋白百分比(%) 8.39 ± 2.13 5.91 ± 0.36 10.960a < 0.001** TC(mmol/L) 4.27 ± 1.10 4.46 ± 0.89 −1.320a 0.188 TG(mmol/L) 1.76 ± 0.94 1.64 ± 0.98 0.801 0.424 HDL-C(mmol/L) 1.14 ± 0.32 1.24 ± 0.33 −2.129 0.035* LDL-C(mmol/L) 2.69 ± 0.93 2.71 ± 0.78 −0.177 0.860 空腹胰岛素(mU/L) 19.53 ± 22.37 11.84 ± 7.47 2.720a 0.017* 餐后2h胰岛素(mU/L) 49.46 ± 35.74 80.72 ± 42.87 −2.980 0.007* 空腹C肽(ng/L) 1.35 ± 0.83 2.08 ± 1.13 −3.143 0.002* 餐后2hC肽(ng/L) 3.60 ± 2.23 9.06 ± 3.56 −5.940a 0.002* FPG(mmol/L) 7.22 ± 2.67 4.94 ± 0.73 7.980a 0.007* 2h-PG(mmol/L) 10.39 ± 3.67 7.09 ± 1.92 7.071a < 0.001** D-2聚体(mg/L) 0.76 ± 1.32 0.47 ± 0.32 2.040a 0.002* FDP(mg/L) 2.44 ± 4.94 1.84 ± 1.31 1.131a 0.262 PT(s) 13.40 ± 1.31 13.15 ± 1.34 1.240 0.220 INR 1.04 ± 0.14 1.04 ± 0.08 0.242a 0.810 FG(g/L) 3.24 ± 0.97 3.07 ± 0.83 1.253 0.210 TT(s) 19.43 ± 1.86 19.19 ± 1.54 0.940 0.351 APTT(s) 38.92 ± 5.69 38.72 ± 5.03 0.253 0.801 AT3(%) 85.05 ± 11.41 85.60 ± 12.11 −0.311 0.758 血小板个数 210.3 ± 61.84 218.5 ± 63.54 −0.910 0.370 血小板压积(%) 0.55 ± 3.12 0.24 ± 0.06 0.991a 0.321 平均体积(fL) 11.84 ± 7.83 11.07 ± 1.16 0.960a 0.344 体积分布宽度(%) 13.74 ± 2.54 13.55 ± 3.01 0.473 0.637 大血小板比率(%) 34.12 ± 8.27 33.32 ± 9.15 0.638 0.524 ACT 144.4 ± 23.31 131.2 ± 23.42 3.841 < 0.001** CR 26.57 ± 6.78 27.28 ± 7.99 −0.653 0.514 PF 2.04 ± 1.15 1.82 ± 1.02 1.370 0.171 注:a表示Satterthwaite近似t值, *P < 0.05 , **P < 0.001。 表 2 D-2聚体、血小板功能与各影响因素相关性分析
Table 2. Correlation analysis between D-2 polymer,platelet function and various factors
指标 D-2聚体(r,P) PF(r,P) 年龄(岁) 0.219,0.009* 0.012,0.887 BMI(kg/m2) 0.177,0.018* −0.043,0.573 收缩压(mm Hg) −0.020,0.784 0.066,0.383 舒张压(mm Hg) 0.003,0.965 −0.036,0.638 糖尿病病程(a) 0.162,0.029* 0.116,0.124 糖化血红蛋白百分比(%) 0.239,0.007* 0.078,0.391 空腹胰岛素(mU/L) 0.072,0.454 −0.031,0.749 餐后2 h胰岛素(mU/L) −0.100,0.314 −0.220,0.027* 空腹C肽(ng/L) −0.070,0.463 −0.033,0.733 餐后2hC肽(ng/L) −0.148,0.131 −0.206,0.037* FPG(mmol/L) 0.051,0.517 0.230,0.004* 2 h-PG(mmol/L) −0.079,0.354 0.058,0.510 *P < 0.05。 表 3 D-2聚体回归方程模型系数
Table 3. D-2 polymer regression equation model coefficient
变量 未标准化偏回归系数 标准化系数 t P 多重共线性诊断VIF b SEb 常数 −3.961 1.549 — −2.557 0.012* — 年龄 0.052 0.021 0.244 2.444 0.017* 1.000 糖化血红蛋白百分比 0.139 0.060 0.230 2.304 0.024* 1.000 *P < 0.05。 表 4 PF回归方程模型系数
Table 4. PF regression equation model coefficient
变量 未标准化偏回归系数 标准化系数 t P 多重共线性诊断VIF b SEb 常数 1.612 0.365 — 4.420 0.001* — 空腹血糖 0.101 0.044 0.235 2.293 0.024* 1.001 餐后2 h胰岛素 −0.006 0.003 −0.204 −1.995 0.049* 1.001 *P < 0.05。 -
[1] 林广玲,黄林锋,邱树彬,等. 2型糖尿病与凝血功能障碍[J]. 中国血液流变学杂志,2005,15(1):86-87. doi: 10.3969/j.issn.1009-881X.2005.01.033 [2] 齐若梅,欧阳涛,高芳堃. 2型糖尿病患者血小板聚集、粘附、ATP释放及血小板平均体积变化的研究[J]. 中国老年学,2003,23(1):13-15. [3] 黄国良,李健榕. 2型糖尿病伴高凝血症的对策与评价[J]. 中国实用内科杂志,2004,24(3):13-15. [4] 禹远远,王瑞英,郝咏梅. 2型糖尿病与内皮细胞功能紊乱[J]. 国外医学:老年医学分册,2008,29(4):165-168. [5] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志,2021,13(4):315-409. [6] 林立. 深静脉血栓形成的危险因素及临床分析[D]. 杭州: 浙江大学硕士学位论文, 2008, [7] 《中国高血压防治指南》修订委员会. 中国高血压防治指南2018年修订版[J]. 心脑血管病防治,2019,19(1):1-44. [8] 中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志,2007,19(5):4-14. [9] Schneider D J. Factors contributing to increased platelet reactivity in people with diabetes[J]. Diabetes Care,2009,32(4):525-527. doi: 10.2337/dc08-1865 [10] Lemkes B A,Hermanides J,Devries J H,et al. Hyperglycemia:a prothrombotic factor?[J]. J Thromb Haemost,2010,8(8):1663-1669. doi: 10.1111/j.1538-7836.2010.03910.x [11] Jose Luis Ferreiro,Dominick J. Angiolillo. Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease[J]. Curr Pharm Des,2012,18(33):5273-5293. doi: 10.2174/138161212803251916 [12] Santilli F,Simeone P,Liani R,et al. Platelets and diabetes mellitus[J]. Prostaglandins Other Lipid Mediat,2015,120(6):28-39. [13] Coban E,Bostan F,Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose[J]. Platelets,2006,17(1):67-69. doi: 10.1080/09537100500220729 [14] Santilli F,Formoso G,Sbraccia P,et al. Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus[J]. Journal of Thrombosis & Haemostasis Jth,2010,8(4):828-837. [15] Wang W,Lau W B,Wang Y,et al. Reduction of CTRP9,a novel anti-platelet adipokine,contributes to abnormal platelet activity in diabetic animals[J]. Cardiovasc Diabetol,2016,15(10):6. [16] Cristofaro R D,Rocca B,Vitacolonna E,et al. Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus[J]. Journal of Thrombosis & Haemostasis,2010,1(2):250-256. [17] Boden G,Rao A K. Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation[J]. Curr Diab Rep,2007,7(3):223-227. doi: 10.1007/s11892-007-0035-1 [18] 付敏,喻谦,刘娟. 2型糖尿病视网膜病变患者血清超敏C反应蛋白和血浆D-二聚体、纤维蛋白原水平及其临床意义[J]. 实用心脑肺血管病杂志,2016,24(6):125-126. [19] 李曼蔚. 检测尿微量白蛋白、血浆纤维蛋白原、D-二聚体和血清超敏C反应蛋白对Ⅱ型糖尿病视网膜病变患者的临床意义[J]. 实验与检验医学,2011,29(5):567-568. doi: 10.3969/j.issn.1674-1129.2011.05.044 [20] Rollini F,Franchi F. Platelet function profiles in patients with diabetes mellitus[J]. J Cardiovasc Transl Res,2013,6(3):329-345. doi: 10.1007/s12265-013-9449-0 [21] 钟宏文,刘江梅,朱丽康,等. 2型糖尿病血小板参数,凝血功能及血液流变学相关性研究[J]. 实验与检验医学,2016,34(3):354-357. doi: 10.3969/j.issn.1674-1129.2016.03.028